{"id":"https://openalex.org/W2075916622","doi":"https://doi.org/10.1186/1471-2334-14-289","title":"A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study","display_name":"A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study","publication_year":2014,"publication_date":"2014-05-23","ids":{"openalex":"https://openalex.org/W2075916622","doi":"https://doi.org/10.1186/1471-2334-14-289","mag":"2075916622","pmid":"https://pubmed.ncbi.nlm.nih.gov/24884578","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4048626"},"language":"en","primary_location":{"id":"doi:10.1186/1471-2334-14-289","doi":"https://doi.org/10.1186/1471-2334-14-289","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2334-14-289","pdf_url":"https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/1471-2334-14-289","source":{"id":"https://openalex.org/S171015910","display_name":"BMC Infectious Diseases","issn_l":"1471-2334","issn":["1471-2334"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/1471-2334-14-289","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010409085","display_name":"Mart\u00edn E. Stryjewski","orcid":"https://orcid.org/0000-0002-4986-6564","observed_orcids":["https://orcid.org/0000-0002-4986-6564"]},"institutions":[{"id":"https://openalex.org/I4210139031","display_name":"Centro de Educaci\u00f3n M\u00e9dica e Investigaciones Cl\u00ednicas Norberto Quirno","ror":"https://ror.org/04czhsq43","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210139031"]}],"countries":["AR"],"is_corresponding":true,"raw_author_name":"Martin E Stryjewski","raw_affiliation_strings":["Department of Medicine, Division of Infectious Diseases, Centro de Educaci\u00f3n M\u00e9dica e Investigaciones Clinicas (CEMIC) \"Norberto Quirno\", Av, Las Heras 2981, Office #3, Capital Federal (C1425ASG), Buenos Aires, Argentina. stryj001@fibertel.com.ar","Department of Medicine, Division of Infectious Diseases, Centro de Educaci\u00f3n M\u00e9dica e Investigaciones Clinicas (CEMIC) \u201cNorberto Quirno\u201d, Capital Federal, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Infectious Diseases, Centro de Educaci\u00f3n M\u00e9dica e Investigaciones Clinicas (CEMIC) \"Norberto Quirno\", Av, Las Heras 2981, Office #3, Capital Federal (C1425ASG), Buenos Aires, Argentina. stryj001@fibertel.com.ar","institution_ids":["https://openalex.org/I4210139031"]},{"raw_affiliation_string":"Department of Medicine, Division of Infectious Diseases, Centro de Educaci\u00f3n M\u00e9dica e Investigaciones Clinicas (CEMIC) \u201cNorberto Quirno\u201d, Capital Federal, Argentina","institution_ids":["https://openalex.org/I4210139031"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039843606","display_name":"Arnold L. Lentnek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1287435762","display_name":"WellStar Health System","ror":"https://ror.org/01kaqt385","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1287435762"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arnold Lentnek","raw_affiliation_strings":["Wellstar Infectious Disease, Marietta, GA, USA","Wellstar Infectious Disease, Marietta, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wellstar Infectious Disease, Marietta, GA, USA","institution_ids":["https://openalex.org/I1287435762"]},{"raw_affiliation_string":"Wellstar Infectious Disease, Marietta, USA","institution_ids":["https://openalex.org/I1287435762"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110473005","display_name":"William D. O\u2019Riordan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William O\u2019Riordan","raw_affiliation_strings":["eStudy Site, San Diego, CA, USA","San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eStudy Site, San Diego, CA, USA","institution_ids":[]},{"raw_affiliation_string":"San Diego, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111673292","display_name":"John R. Pullman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802731940","display_name":"Butte College","ror":"https://ror.org/02zq8st27","country_code":"US","type":"education","lineage":["https://openalex.org/I2802731940"]},{"id":"https://openalex.org/I4405262450","display_name":"Montana Bureau of Mines and Geology","ror":"https://ror.org/03db6jy14","country_code":"US","type":"government","lineage":["https://openalex.org/I4405262450","https://openalex.org/I917168660"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Pullman","raw_affiliation_strings":["Mercury Street Medical Group, Butte, MT, USA","Mercury Street Medical Group, Butte, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mercury Street Medical Group, Butte, MT, USA","institution_ids":["https://openalex.org/I2802731940","https://openalex.org/I4405262450"]},{"raw_affiliation_string":"Mercury Street Medical Group, Butte, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041779107","display_name":"Paul Anantharajah Tambyah","orcid":"https://orcid.org/0000-0003-0405-771X","observed_orcids":["https://orcid.org/0000-0003-0405-771X"]},"institutions":[{"id":"https://openalex.org/I4210150261","display_name":"National University Health System","ror":"https://ror.org/05tjjsh18","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596","https://openalex.org/I4210150261"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Paul Anantharajah Tambyah","raw_affiliation_strings":["Department of Medicine, National University Health System, Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, National University Health System, Singapore, Singapore","institution_ids":["https://openalex.org/I4210150261"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107824337","display_name":"Jos\u00e9 Maria Mir\u00f3","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose M Mir\u00f3","raw_affiliation_strings":["Infectious Diseases Service, Hospital Clinic\u2013Institut d\u2019investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Service, Hospital Clinic\u2013Institut d\u2019investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045500368","display_name":"Vance G. Fowler","orcid":"https://orcid.org/0000-0002-8048-0897","observed_orcids":["https://orcid.org/0000-0002-8048-0897"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vance G Fowler Jr","raw_affiliation_strings":["Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, NC, USA","Duke Clinical Research Institute, Durham, NC, USA","Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, USA","Duke Clinical Research Institute, Durham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC, USA","institution_ids":["https://openalex.org/I4405286153"]},{"raw_affiliation_string":"Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, USA","institution_ids":["https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113504436","display_name":"Steven L. Barriere","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven L Barriere","raw_affiliation_strings":["Theravance, Inc, South San Francisco, CA, USA","Theravance, Inc, South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance, Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210133216"]},{"raw_affiliation_string":"Theravance, Inc, South San Francisco, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108409555","display_name":"Michael M. Kitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael M Kitt","raw_affiliation_strings":["Theravance, Inc, South San Francisco, CA, USA","Theravance, Inc, South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance, Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210133216"]},{"raw_affiliation_string":"Theravance, Inc, South San Francisco, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062306774","display_name":"G. Ralph Corey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G Ralph Corey","raw_affiliation_strings":["Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, NC, USA","Duke Clinical Research Institute, Durham, NC, USA","Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, USA","Duke Clinical Research Institute, Durham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC, USA","institution_ids":["https://openalex.org/I4405286153"]},{"raw_affiliation_string":"Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, USA","institution_ids":["https://openalex.org/I4405286153"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5010409085"],"corresponding_institution_ids":["https://openalex.org/I4210139031"],"apc_list":{"value":3090,"currency":"USD","value_usd":3090},"apc_paid":{"value":3090,"currency":"USD","value_usd":3090},"fwci":7.5707,"has_fulltext":true,"cited_by_count":69,"citation_normalized_percentile":{"value":0.98032935,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"14","issue":"1","first_page":"289","last_page":"289"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/telavancin","display_name":"telavancin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/staphylococcus-aureus-bacteremia","display_name":"Staphylococcus aureus bacteremia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/methicillin-resistant-staphylococcus-aureus","display_name":"methicillin-resistant Staphylococcus aureus","score":0.9470000267028809},{"id":"https://openalex.org/keywords/lipoglycopeptide","display_name":"lipoglycopeptide","score":0.8289999961853027},{"id":"https://openalex.org/keywords/vancomycin","display_name":"vancomycin","score":0.8309999704360962},{"id":"https://openalex.org/keywords/clinical-cure","display_name":"clinical cure","score":0.6579999923706055},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7620000243186951},{"id":"https://openalex.org/keywords/serum-creatinine","display_name":"serum creatinine","score":0.7300000190734863},{"id":"https://openalex.org/keywords/catheter-related-bacteremia","display_name":"catheter-related bacteremia","score":0.7070000171661377}],"concepts":[{"id":"https://openalex.org/C190139176","wikidata":"https://www.wikidata.org/wiki/Q598976","display_name":"Medical microbiology","level":2,"score":0.8409397006034851},{"id":"https://openalex.org/C2779443120","wikidata":"https://www.wikidata.org/wiki/Q650912","display_name":"Bacteremia","level":3,"score":0.7407113313674927},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6801454424858093},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.6432085037231445},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5166125893592834},{"id":"https://openalex.org/C190612196","wikidata":"https://www.wikidata.org/wiki/Q180502","display_name":"Parasitology","level":2,"score":0.5097290873527527},{"id":"https://openalex.org/C2777052132","wikidata":"https://www.wikidata.org/wiki/Q595158","display_name":"Methicillin-resistant Staphylococcus aureus","level":4,"score":0.43399015069007874},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4111875295639038},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.31341034173965454},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14881974458694458},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.13672930002212524},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.1206807792186737},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.08730760216712952},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.06755122542381287},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077427","descriptor_name":"Lipoglycopeptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000617","descriptor_name":"Aminoglycosides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000617","descriptor_name":"Aminoglycosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010406","descriptor_name":"Penicillins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013203","descriptor_name":"Staphylococcal Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013203","descriptor_name":"Staphylococcal Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D013211","descriptor_name":"Staphylococcus aureus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013211","descriptor_name":"Staphylococcus aureus","qualifier_ui":"Q000472","qualifier_name":"pathogenicity","is_major_topic":true},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016470","descriptor_name":"Bacteremia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016470","descriptor_name":"Bacteremia","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055499","descriptor_name":"Catheter-Related Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D055499","descriptor_name":"Catheter-Related Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D055624","descriptor_name":"Methicillin-Resistant Staphylococcus aureus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D055624","descriptor_name":"Methicillin-Resistant Staphylococcus aureus","qualifier_ui":"Q000472","qualifier_name":"pathogenicity","is_major_topic":false}],"locations_count":10,"locations":[{"id":"doi:10.1186/1471-2334-14-289","doi":"https://doi.org/10.1186/1471-2334-14-289","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2334-14-289","pdf_url":"https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/1471-2334-14-289","source":{"id":"https://openalex.org/S171015910","display_name":"BMC Infectious Diseases","issn_l":"1471-2334","issn":["1471-2334"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3023675","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4048626","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24884578","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24884578","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC infectious diseases","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:diposit.ub.edu:2445/102008","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2445/102008","pdf_url":null,"source":{"id":"https://openalex.org/S4306401653","display_name":"Dip\u00f2sit Digital de la Universitat de Barcelona (Universitat de Barcelona)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I71999127","host_organization_name":"Universitat de Barcelona","host_organization_lineage":["https://openalex.org/I71999127"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Articles publicats en revistes (Medicina)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4048626","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4048626/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Infect Dis","raw_type":"Text"},{"id":"pmh:oai:scholarbank.nus.edu.sg:10635/143213","doi":null,"is_oa":false,"landing_page_url":"http://scholarbank.nus.edu.sg/handle/10635/143213","pdf_url":null,"source":{"id":"https://openalex.org/S7407052290","display_name":"National University of Singapore","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Scopus","raw_type":"Article"},{"id":"pmh:oai:dukespace.lib.duke.edu:10161/13314","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10161/13314","pdf_url":null,"source":{"id":"https://openalex.org/S4306400687","display_name":"DukeSpace (Duke University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I170897317","host_organization_name":"Duke University","host_organization_lineage":["https://openalex.org/I170897317"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"},{"id":"pmh:oai:www.recercat.cat:2072/266894","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2445/102008","pdf_url":null,"source":{"id":"https://openalex.org/S4306402147","display_name":"RECERCAT (Consorci de Serveis Universitaris de Catalunya)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210090028","host_organization_name":"Consorci de Serveis Universitaris de Catalunya","host_organization_lineage":["https://openalex.org/I4210090028"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"doi:10.60692/eaj1g-66d04","doi":"https://doi.org/10.60692/eaj1g-66d04","is_oa":true,"landing_page_url":"https://doi.org/10.60692/eaj1g-66d04","pdf_url":null,"source":{"id":"https://openalex.org/S7407051682","display_name":"Greater South Information System","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},{"id":"doi:10.60692/kqrgk-zhn82","doi":"https://doi.org/10.60692/kqrgk-zhn82","is_oa":true,"landing_page_url":"https://doi.org/10.60692/kqrgk-zhn82","pdf_url":null,"source":{"id":"https://openalex.org/S7407051682","display_name":"Greater South Information System","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.1186/1471-2334-14-289","doi":"https://doi.org/10.1186/1471-2334-14-289","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2334-14-289","pdf_url":"https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/1471-2334-14-289","source":{"id":"https://openalex.org/S171015910","display_name":"BMC Infectious Diseases","issn_l":"1471-2334","issn":["1471-2334"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2075916622.pdf","grobid_xml":"https://content.openalex.org/works/W2075916622.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1997692689","https://openalex.org/W2002249283","https://openalex.org/W2008192713","https://openalex.org/W2044368480","https://openalex.org/W2061311514","https://openalex.org/W2074827635","https://openalex.org/W2082441919","https://openalex.org/W2091397788","https://openalex.org/W2106559391","https://openalex.org/W2108433768","https://openalex.org/W2114585210","https://openalex.org/W2116900840","https://openalex.org/W2119375374","https://openalex.org/W2123175723","https://openalex.org/W2125806378","https://openalex.org/W2126237265","https://openalex.org/W2130566249","https://openalex.org/W2140764008","https://openalex.org/W2140880071","https://openalex.org/W2142848829","https://openalex.org/W2146453096","https://openalex.org/W2147723850","https://openalex.org/W2149700339","https://openalex.org/W2152346281","https://openalex.org/W2155139966","https://openalex.org/W2168482920","https://openalex.org/W2170167852","https://openalex.org/W2206769039","https://openalex.org/W4214754383"],"related_works":["https://openalex.org/W2341696517","https://openalex.org/W7098568909","https://openalex.org/W7098039214","https://openalex.org/W2796116512","https://openalex.org/W3020925562","https://openalex.org/W2730055997","https://openalex.org/W2762164263","https://openalex.org/W2127383645","https://openalex.org/W2580074459","https://openalex.org/W3165442274"],"abstract_inverted_index":{"BACKGROUND:":[0],"Staphylococcus":[1,259],"aureus":[2,26,41,68,137,248],"bacteremia":[3,138,166,174],"is":[4,15],"a":[5,16,30],"common":[6,133,187,226],"infection":[7],"associated":[8],"with":[9,38,164,172],"significant":[10,210],"morbidity":[11],"and":[12,87,99,110,139,157,169,217],"mortality.":[13],"Telavancin":[14],"bactericidal":[17],"lipoglycopeptide":[18],"active":[19],"against":[20],"Gram-positive":[21],"pathogens,":[22],"including":[23],"methicillin-resistant":[24],"S.":[25,40,67,136,247],"(MRSA).":[27],"We":[28],"conducted":[29],"randomized,":[31],"double-blind,":[32],"Phase":[33],"2":[34],"trial":[35],"in":[36,153,178,188,204,212,227],"patients":[37,84,96,112,142,150,163],"uncomplicated":[39,246],"bacteremia.":[42,69],"METHODS:":[43],"Patients":[44],"were":[45,62,85,113,130,151,167,185,201,224],"randomized":[46,86],"to":[47,64,198],"either":[48],"telavancin":[49,155,190,229,239],"or":[50,54],"standard":[51,107,119,158],"therapy":[52,108,120,159],"(vancomycin":[53],"anti-staphylococcal":[55],"penicillin)":[56],"for":[57,243,255],"14":[58],"days.":[59,79],"Continuation":[60],"criteria":[61,101],"set":[63],"avoid":[65],"complicated":[66],"The":[70],"primary":[71],"end":[72],"point":[73],"was":[74,125],"clinical":[75],"cure":[76],"at":[77,218],"84":[78],"RESULTS:":[80],"In":[81],"total,":[82],"60":[83,126],"58":[88],"received":[89],"\u22651":[90],"study":[91,176,236],"medication":[92],"dose":[93],"(all-treated),":[94],"31":[95],"fulfilled":[97],"inclusion/exclusion":[98],"continuation":[100],"(all-treated":[102],"target":[103],"[ATT])":[104],"(telavancin":[105,117],"15,":[106],"16),":[109],"17":[111],"clinically":[114,209],"evaluable":[115],"(CE)":[116],"8,":[118],"9).":[121],"Mean":[122],"age":[123],"(ATT)":[124],"years.":[127],"Intravenous":[128],"catheters":[129],"the":[131,154,189,228],"most":[132],"source":[134],"of":[135,141,148,245,257],"~50%":[140],"had":[143],"MRSA.":[144],"A":[145],"similar":[146,202],"proportion":[147],"CE":[149],"cured":[152,168],"(88%)":[156],"(89%)":[160],"groups.":[161],"All":[162],"MRSA":[165],"one":[170],"patient":[171],"MSSA":[173],"failed":[175],"treatment":[177,206,244],"each":[179],"group.":[180],"Although":[181],"adverse":[182],"events":[183],"(AEs)":[184],"more":[186,225],"ATT":[191],"group":[192,230],"(90%":[193],"vs.":[194,232],"72%),":[195],"AEs":[196],"leading":[197],"drug":[199],"discontinuation":[200],"(7%)":[203],"both":[205],"arms.":[207],"Potentially":[208],"increases":[211],"serum":[213],"creatinine":[214],"(\u22651.5":[215],"mg/dl":[216],"least":[219],"50%":[220],"greater":[221],"than":[222],"baseline)":[223],"(20%":[231],"7%).":[233],"CONCLUSIONS:":[234],"This":[235],"suggests":[237],"that":[238],"may":[240],"have":[241],"utility":[242],"bacteremia;":[249],"additional":[250],"studies":[251],"are":[252],"warranted.":[253],"(Telavancin":[254],"Treatment":[256],"Uncomplicated":[258],"Aureus":[260],"Bacteremia":[261],"(ASSURE);":[262],"NCT00062647).":[263]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}